Unreported / Non-Citable
Background
C.D., identified by the court as “Cate,” was charged with one or more third-degree felonies and found incompetent to stand trial. After she was committed to North Texas State Hospital, her treating psychiatrist applied for authorization to administer psychoactive medication involuntarily.
The psychiatrist testified that Cate had delusional disorder, consistently refused medication, and could not meaningfully participate in competency-restoration treatment. Cate had not been physically or verbally aggressive at the hospital, however, and the psychiatrist testified that she was not dangerous to herself or anyone there. The trial court found that Cate lacked capacity to decide whether to take the medication and that treatment was in her best interest, then authorized its administration.
The Court’s Holding
The Second Court of Appeals held that the four-factor test from Sell v. United States governed because the medication was sought to restore Cate’s competency for trial, not to address dangerousness or a risk to her health. The final order contained no dangerousness finding, and the evidence did not show that Cate’s health would be endangered without medication.
Although the State had an important interest in prosecuting Cate for a serious offense and the psychiatrist testified that medication was likely to help restore competency, the State presented no evidence about possible side effects. It therefore failed to establish the second Sell factor, which required proof that the medication was substantially unlikely to cause side effects significantly interfering with Cate’s ability to assist in her defense. The court reversed the authorization order and rendered judgment denying the State’s application without reaching the remaining Sell factors or Cate’s separate sufficiency challenge.
Key Takeaways
- The Sell test applies when involuntary medication is sought to restore competency and is not independently justified by dangerousness or a threat to the defendant’s health.
- Evidence that medication will likely improve a defendant’s condition or restore competency does not alone satisfy Sell’s second factor.
- The State must present evidence that the proposed medication is substantially unlikely to cause side effects that would significantly impair the defendant’s ability to assist in the defense.
Why It Matters
The decision underscores that an involuntary-medication order requires evidence addressing every applicable constitutional element, not merely general findings that treatment is beneficial or medically appropriate. When competency restoration is the sole justification, the absence of evidence concerning trial-related side effects can require rendition of judgment denying the State’s application.